#fda-regulations

#fda-regulations

RFK Jr.'s potential appointment could bring significant attention to food additive regulations and public health concerns.

RFK Jr. could significantly influence health policy if confirmed, but complicated bureaucratic structures may hinder his initiatives.

Many fruit snacks contain minimal real fruit, misleading consumers about their nutritional value.

Valisure, a tiny laboratory in Connecticut, has detected harmful chemicals in widely used medications, leading to product recalls and increased awareness of product safety issues.

Federal food safety regulators warned Bimbo Bakeries USA for mislabeling allergens on their products, impacting 33 million Americans with food allergies.

Rizo Lopez Foods recalled products linked to a listeria outbreak that caused two deaths, leading to a federal court injunction against its operations.

Walmart recalled Great Value apple juice due to elevated levels of arsenic posing a potential health hazard.

The recall involves 9,535 cases of apple juice prior to the FDA's action level guidelines.

The FDA has removed the only authorized use of BVO in the food supply due to safety concerns and adverse health effects.

Many beverage makers have already reformulated their products to replace BVO with alternative ingredients, with few beverages in the U.S. still containing BVO.

Bagged ice, though commonly regarded as safe, can harbor bacteria and disease-causing pathogens due to inadequate regulation and production methods.

Dense breast tissue significantly increases cancer risk, yet women often lack guidance on their diagnosis and next steps.

Recent FDA regulations will improve communication regarding breast density following mammograms.

Mammography facilities must notify patients about breast density to enhance early breast cancer detection starting Sep. 10, 2024.

Breast density can obscure cancer detection in mammograms, prompting the need for updated screening guidelines and communication about risks.

The surge in compounded GLP-1 drugs addresses availability but leads to regulatory issues and legal battles.

Compounding offers personalized medication options, even amidst drug shortages.

Compounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.

The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.

The obscurity of a federal statute is enabling US pharmacies to flood the market with unvetted knockoffs of popular weight-loss drug Ozempic.

Hims & Hers Health capitalized on weight-loss drug market trends while facing new competition from Eli Lilly's FDA-approved product offerings.

Compounded weight-loss drugs can offer a more affordable option compared to brand-name medications like Wegovy, potentially benefiting those struggling with insurance coverage and high costs.

Amish farmer Amos Miller faced legal challenges for selling unpasteurized raw milk products, without a permit, despite a loyal private customer base.

The Supreme Court is hearing controversial abortion cases post-Dobbs v. Jackson Women's Health Organization.

One case involves challenging FDA regulations on mifepristone for medication abortions, potentially impacting access to the drug.

The U.S. Supreme Court's decision prevents restrictions on nationwide access to the abortion pill mifepristone, but concerns persist over medication abortion access and FDA regulations.

The U.S. Supreme Court may change how the FDA interacts with regulated industries based on decisions regarding monitoring costs for fishing vessels.

The U.S. Supreme Court is considering the fate of the abortion pill mifepristone in a case that could have significant implications for reproductive healthcare access.

This case could potentially restrict access to medication abortion in the U.S., affecting states where abortion is legal and potentially reversing previous progress in abortion rights.

The U.S. Supreme Court will review the FDA's rejection of marketing new flavored vaping products, questioning FDA's decision-making process under the Family Smoking Prevention and Tobacco Control Act.

The FDA's 1938 law hampers the approval process for better, more effective sunscreen ingredients, blocking Americans from access to superior sun protection.

Americans may not have access to advanced sunscreens due to outdated FDA regulations.

Consumers deserve to easily understand food's nutritional value for informed decisions, particularly for ingredients like sugar.

Ultra-processed foods can contribute to health conditions like anxiety and cancer through associations, not causation.

FDA is considering implementing new labeling to help consumers identify healthier food choices and understand nutritional value.

The Supreme Court issued decisions upholding abortion access in recent cases, rejecting challenges to FDA's changes and clarifying conflicts between state and federal laws.

The Supreme Court dismissed a major abortion-related case due to lack of legal standing, preserving access to mifepristone without ruling on the case's merits.

The Supreme Court is considering FDA regulations on mifepristone.

Pre-2016 rules could limit access to medication abortion.

The Supreme Court case on mifepristone could impact FDA regulations broadly.

FDA oversight could face challenges affecting various medications and therapies.